Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Mohr

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Pharmazie in Unserer Zeit|October 23, 2004
[The pharmacology of estrogens]Klaus Mohr
Nature Chemical Biology|July 19, 2014
Allostery: A GPCR's back doorKlaus Mohr, Evi Kostenis
Drug Discovery Today. Technologies|September 21, 2013
Dualsteric GPCR targeting and functional selectivity: the paradigmatic M(2) muscarinic acetylcholine receptorAndreas Bock, Klaus Mohr
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 20, 2013
A muscarinic view on GqKlaus Mohr, Christian Tränkle
Pharmazie in Unserer Zeit|April 16, 2004
[H1 antihistamines: pharmacologic basis and action]Andreas Dittmann, Klaus Mohr
Nature Chemical Biology|November 17, 2011
Signaling pathways: Purinosomes under GPCR controlKlaus Mohr, Evi Kostenis
Medizinische Monatsschrift Fur Pharmazeuten|July 3, 2004
[Muscarinic acetylcholine receptors as target structures for drugs. Old and new mechanisms]Uta Voigtländer, Klaus Mohr
Pharmazie in Unserer Zeit|October 23, 2010
[The blood circulating in the body is distributed by a richly branched vasculature to tissues and organs]Ulrike Holzgrabe, Klaus Mohr
Pharmazie in Unserer Zeit|October 25, 2007
[Angiogenesis inhibitors for vision loss. Ranibizumab for macular degeneration]Marion Mohr-Andrä, Klaus Mohr
Neuropharmacology|September 23, 2017
Allosteric modulators targeting CNS muscarinic receptorsAndreas Bock, Ramona Schrage, Klaus Mohr
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Pharmazie in Unserer Zeit|October 23, 2004
[The pharmacology of estrogens]Klaus Mohr
Nature Chemical Biology|July 19, 2014
Allostery: A GPCR's back doorKlaus Mohr, Evi Kostenis
Drug Discovery Today. Technologies|September 21, 2013
Dualsteric GPCR targeting and functional selectivity: the paradigmatic M(2) muscarinic acetylcholine receptorAndreas Bock, Klaus Mohr
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 20, 2013
A muscarinic view on GqKlaus Mohr, Christian Tränkle
Pharmazie in Unserer Zeit|April 16, 2004
[H1 antihistamines: pharmacologic basis and action]Andreas Dittmann, Klaus Mohr
Nature Chemical Biology|November 17, 2011
Signaling pathways: Purinosomes under GPCR controlKlaus Mohr, Evi Kostenis
Medizinische Monatsschrift Fur Pharmazeuten|July 3, 2004
[Muscarinic acetylcholine receptors as target structures for drugs. Old and new mechanisms]Uta Voigtländer, Klaus Mohr
Pharmazie in Unserer Zeit|October 23, 2010
[The blood circulating in the body is distributed by a richly branched vasculature to tissues and organs]Ulrike Holzgrabe, Klaus Mohr
Pharmazie in Unserer Zeit|October 25, 2007
[Angiogenesis inhibitors for vision loss. Ranibizumab for macular degeneration]Marion Mohr-Andrä, Klaus Mohr
Neuropharmacology|September 23, 2017
Allosteric modulators targeting CNS muscarinic receptorsAndreas Bock, Ramona Schrage, Klaus Mohr
Pageof 7